NCT05625503View on ClinicalTrials.gov

Dilution of Verapamil During Intraarterial Administration

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Vasospasm;PeripheralBurningPain
Interventions
DRUG

Verapamil

All patients routinely receive intra-arterial calcium channel blockers during transradial access for coronary angiography.

DRUG

Nicardipine

Calcium channel blocker

Trial Locations (1)

60612

University of Illinois Hospital, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER